Zolinza Capsule
Product Images NDC 0006-0568

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Zolinza (NDC 0006-0568). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zolinza 01)

Chemical structure diagram of the active ingredient vorinostat, showing its molecular configuration with labeled bonds and rings.*

FDA Label Image

Principal Display Panel (100 mg Capsule Bottle Label)

ZOLINZA 100 mg capsules label showing vorinostat as the active ingredient. The label indicates the product is an oral capsule with 120 capsules per bottle, manufactured by Merck Sharp & Dohme LLC. It includes a warning about avoiding direct contact of the powder with skin or mucous membranes and instructions for storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.